article thumbnail

QMS market to value nearly $4b by 2030

European Pharmaceutical Review

billion by 2030. Since most pharmaceutical manufacturers export their products to North America and Europe, the need for documents such as process management, corrective and preventive actions (CAPA), deviations, training, quality management, and product release documents is vital.

article thumbnail

Vision for consultant pharmacists by 2030 unveiled by RPS

Hospital Pharmacy Europe

The vision sets out a multifaceted approach under five strategic pillars to help to ensure consultant pharmacists are an integral part of the pharmacy and wider healthcare team in all sectors of the UK by 2030. The post Vision for consultant pharmacists by 2030 unveiled by RPS appeared first on Hospital Pharmacy Europe.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

EU authority adopts recommendations to boost fight against AMR by 2030

Pharmaceutical Technology

The recommendations to combat AMR propose that there should be a 20% reduction in the total human consumption of antibiotics by 2030 alongside an even larger pushback against their use in animals, per the 13 June announcement. Farm animal welfare should also be improved to lower the chances of infectious diseases in farming.

article thumbnail

FIP encourages sharing best practice to facilitate pharmacy workforce transformation

Hospital Pharmacy Europe

The recommendations are part of the ‘ FIP Brisbane Calls to Action ’ consensus document, which urges the 156 FIP national member organisations, individual members and global pharmacy agencies to accelerate pharmaceutical workforce transformation.

article thumbnail

STAT+: Pharmalittle: Woodcock to retire from the FDA; Acrotech urged to speed up confirmatory study of cancer drugs

STAT

 The company’s final study plan was submitted to the FDA in 2022 and is expected to be completed  by 2030 , according to FDA briefing documents published earlier this week. They were approved under the FDA accelerated pathway in 2009 and 2014, respectively, for treating a rare form of blood cancer. The

FDA 90
article thumbnail

Establishing quality assurance in personalised preparations

European Pharmaceutical Review

QMS market to value nearly $4b by 2030 A strategy for improving drug product quality Uriel et al. The data obtained is included in two documents and sent to all participants in the test: An individual report with details of the results specific to each participant. These are documented and their root cause is sought.

article thumbnail

First COVID-19 impact report on global vaccine markets

European Pharmaceutical Review

The document showed that in 2021, approximately 16 billion vaccine doses, worth $141 billion, were supplied across 47 vaccines and 94 manufacturers. Achieving Immunization Agenda 2030 goals. WHO is calling for much-needed changes to the global vaccine market to save lives, prevent disease and prepare for future crises.”